Baltimore R&D Tax Credit Overview for Businesses

R&D Tax Credits for Baltimore, Maryland Businesses

Baltimore, Maryland, is a hub for industries such as healthcare, education, technology, and manufacturing. Top companies in the city include Johns Hopkins Hospital, a leading healthcare provider; the University of Maryland, a key educational institution; Under Armour, a prominent technology company; T. Rowe Price, a major financial services provider; and McCormick & Company, a major food production company. The Research and Development (R&D) Tax Credit can help these industries reduce their tax liabilities, foster innovation, and enhance business performance.

find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 145 West Ostend Street, Baltimore, Maryland provides R&D tax credit consulting and advisory services to Baltimore and the surrounding areas such as: Columbia, Germantown, Silver Spring, Waldorf and Glen Burnie.

If you have any questions or need further assistance, please call or email our local Maryland Partner on (443) 687-8701.
Feel free to book a quick teleconference with one of our Maryland R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Baltimore, Maine Patent of the Year – 2024/2025

Sonavex Inc. has been awarded the 2024/2025 Patent of the Year for its innovation in ultrasound-visible medical implants. Their invention, detailed in U.S. Patent No. 11858181, titled ‘Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity’, utilizes microcavity-enhanced polymer structures to improve ultrasound visibility from multiple angles.

Traditional implants often suffer from poor ultrasound visibility when the probe is not aligned directly with the device. Sonavex’s technology addresses this by embedding microscopic gas-filled cavities within the implant material. These microcavities scatter ultrasound waves diffusely, ensuring consistent visibility regardless of the probe’s orientation.

This advancement is particularly beneficial in procedures requiring precise implant placement and monitoring, such as vascular surgeries. Enhanced visibility can lead to more accurate assessments and potentially reduce the need for additional imaging procedures.

The implants are designed to maintain structural integrity while providing clear imaging. They can be manufactured using standard polymer processing techniques, facilitating integration into existing medical device production lines.

Sonavex’s development represents a significant step forward in medical imaging and implant technology. By improving the echogenicity of implants, healthcare providers can achieve better outcomes through enhanced visualization during and after surgical procedures.